SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
10-Q	Quarterly report which provides a continuing view of a company's financial position	Aug 04, 2023	View HTML 0000950170-23-038514.pdf 0000950170-23-038514.rtf 0000950170-23-038514.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
10-Q	Quarterly report which provides a continuing view of a company's financial position	Nov 03, 2023	View HTML 0000950170-23-058775.pdf 0000950170-23-058775.rtf 0000950170-23-058775.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
10-Q	Quarterly report which provides a continuing view of a company's financial position	May 09, 2024	View HTML 0000950170-24-056380.pdf 0000950170-24-056380.rtf 0000950170-24-056380.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
S-3/A	Pre-effective amendment to an S-3 filing	Jan 17, 2013	View HTML 0001193125-13-015801.pdf 0001193125-13-015801.rtf 0001193125-13-015801.xls
S-3/A	Pre-effective amendment to an S-3 filing	Aug 17, 2018	View HTML 0001193125-18-251126.pdf 0001193125-18-251126.rtf 0001193125-18-251126.xls
S-3/A	Pre-effective amendment to an S-3 filing	Oct 31, 2018	View HTML 0001193125-18-314121.pdf 0001193125-18-314121.rtf 0001193125-18-314121.xls
S-3/A	Pre-effective amendment to an S-3 filing	May 05, 2021	View HTML 0001193125-21-151688.pdf 0001193125-21-151688.rtf 0001193125-21-151688.xls
POS AM	Post-effective amendment to an S-Type filing	Jun 20, 2008	View HTML 0001193125-08-136862.pdf 0001193125-08-136862.rtf 0001193125-08-136862.xls
POS AM	Post-effective amendment to an S-Type filing	Jun 20, 2008	View HTML 0001193125-08-136863.pdf 0001193125-08-136863.rtf 0001193125-08-136863.xls
POS AM	Post-effective amendment to an S-Type filing	Jul 03, 2008	View HTML 0001193125-08-146757.pdf 0001193125-08-146757.rtf 0001193125-08-146757.xls

Data provided by Kaleidoscope.